This company seems to have been delisted
Reason: Rebranded as Artivion (AORT)
Source: https://www.prnewswire.com/news-releases/cryolife-announces-corporate-rebranding-and-changes-name-to-artivion-301462581.html
Reason: Rebranded as Artivion (AORT)
Source: https://www.prnewswire.com/news-releases/cryolife-announces-corporate-rebranding-and-changes-name-to-artivion-301462581.html
CryoLife
CRY
$17.88
Share price
1.42%
Change (1 day)
-21.51%
Change (1 year)
Categories
Earnings for CryoLife (CRY)
Earnings in 2021 (TTM): $2.06 Million USD
According to CryoLife's latest financial reports the company's current earnings are $0.29 Billion USD. In 2020 the company made an earning of -$0.48 Million USD a decrease over its 2019 earnings that were of $16.53 Million USD.
Earnings history for CryoLife from 2001 to 2021
Annual earnings
| Year | Earnings | Change |
|---|---|---|
| 2021 (TTM) | $2.06 M | -532.77% |
| 2020 | -$0.48 Million | -102.88% |
| 2019 | $16.53 M | 75.91% |
| 2018 | $9.39 M | 11.31% |
| 2017 | $8.44 M | -60.65% |
| 2016 | $21.45 M | 268.77% |
| 2015 | $5.81 M | -33.3% |
| 2014 | $8.72 M | -62.67% |
| 2013 | $23.36 M | 91.01% |
| 2012 | $12.23 M | 5.37% |
| 2011 | $11.6 M | 55.67% |
| 2010 | $7.45 M | -48.35% |
| 2009 | $14.43 M | 4.62% |
| 2008 | $13.79 M | 66.27% |
| 2007 | $8.29 M | -790.43% |
| 2006 | -$1.21 Million | -94.02% |
| 2005 | -$20.09 Million | -7.93% |
| 2004 | -$21.82 Million | -25.34% |
| 2003 | -$29.23 Million | -26.88% |
| 2002 | -$39.97 Million | -420.72% |
| 2001 | $12.46 M |
Earnings for similar companies or competitors
| Company | Earnings | Earnings differencediff. | Country |
|---|---|---|---|
 Baxter BAX | -$0.72 Billion | -34,663.11% | 🇺🇸 USA |
 Edwards Lifesciences EW | $1.62 B | 78,662.14% | 🇺🇸 USA |
 Medtronic MDT | $6.35 B | 308,492.23% | 🇮🇪 Ireland |
 Stryker Corporation SYK | $3.33 B | 161,696.12% | 🇺🇸 USA |
 Integra LifeSciences IART | $32.78 M | 1,491.31% | 🇺🇸 USA |
 Boston Scientific BSX | $2.47 B | 120,239.81% | 🇺🇸 USA |
 Teleflex TFX | $0.28 B | 13,960.00% | 🇺🇸 USA |
 Johnson & Johnson JNJ | $27.40 B | 1,330,385.44% | 🇺🇸 USA |